Meda Pharmaceuticals Inc. is the U.S. subsidiary of Meda AB.
The Meda Pharmaceutical product portfolio is focused primarily on respiratory, allergy, central nervous system, gastroenterology, musculoskeletal, rheumatology, erectile dysfunction, and women's health products.
Latest News
December 11, 2011:
Meda announces PDUFA timeline for Dymista »
December 6, 2011:
Astepro patent granted »
December 11, 2011:
Meda announces PDUFA timeline for Dymista »
December 6, 2011:
Astepro patent granted »
Independent Education Grants
Meda Pharmaceuticals Inc. supports bona fide educational programs through the provision of educational grants.
Meda Pharmaceuticals Inc. supports bona fide educational programs through the provision of educational grants.









